Ha EVS, Rogers DF. Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases. Pharmacology 2016;97:84–100.

Paulissen G; Rocks N; Gueders MM, et al. Role of ADAM and ADAMTS metalloproteinases in airway diseases. Respir Res 2009;10:127-127 (1 p).

Fahy JV, Dickey DF. Airway mucus function and dysfunction. N Engl J Med 2010;363(23):2233-47.

Rubin BK. Secretion properties, clearance, and therapy in airway disease. Translational Respiratory Medicine 2014;2:6.

Ramos FL, Krahnke JS, Kim V. Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis 2014;9:139–150.

Putcha N, Han MK, Martinez CH, et al. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. J COPD F. 2014; 1(1): 105-114.

Buist AS. The US Lung Health Study. Respirology 1997;2(4):303-307.

Hartman JE, Prinzen J, van Lummel RC, ten Hacken NHT. Frequent sputum production is associated with disturbed night’s rest an impaired sleep quality in patients with COPD. Sleep Breath 2015;19(4):1125-1133.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Updated 2016). 2016. http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/ Accessed May 11, 2016.

Schönhofer B, Geiseler J, Dellweg D, et al. S2k-guideline “prolonged weaning”. Pneumologie. 2015;69(10):595-607.

Winck JC, Concalves MR, Lourenco C, et al. Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest 2004;126(3):774-780.

Cotgreave IA, Eklund A, Larsson K, Moldeus P. No penetration of orally administered N‐acetylcysteine into bronchoalveolar lavage fluid. Eur J Respir Dis 1987;70:73–77.

Bateman ED, Rennard S, Barnes PJ, et al. Alternative mechanisms for tiotropium. Pulm Pharm Therapeutics 2009;22(6):533-542.

Strickland SL, Rubin BK, Drescher GS, et al. AARC clinical practice guideline: Effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients. Respiratory Care 2013;58(12): 2187-2193.

Venturelli E, Crisafulli E, Debiase A, et al. Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO (R) project: a multicentre randomized controlled trial. Clin Rehabil 2013; 27 (4): 336-346. The UNIKO (R) project: a multicentre randomized controlled trial. Clin Rehabil 2013; 27 (4): 336-346.

Sturgess JM, Palfrey AJ, Reid L. The viscosity of bronchial secretion. Clinical Science. 1970;38:145–156.

King RJ. Pulmonary surfactant. J Appl Physiol respir Environ Exerc Physiol 1982;53(1):1-8.

Marti JD, Basi GL, Monserrat R, Torres A. Effects of manual rib cage compressions on expiratory flow and mucus clearance during mechanical ventilation. Crit Car Med 2013;41(3).

Zucker T, Skjodt NM, Jones RL, et al. Effects of high-frequency chest wall oscillation on pleural pressure and oscillated flow. Biomed Instrument Technol 2008;42(6);485-491.

Galie N, Hinderliter AL,Torbicki A, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographical and Doppler measures in patients with pulmonary artrial hypertension. J am Coll Cardiol 2003;41(3):1380-1386.